1． Mangano DT. Perioperative cardiac morbidity. Anesthesiology， 1990， 72：153-184.

2． Katz RI， Barnhart JM， Ho G， et al. A survey on the intended purposes and perceived utility of preoperative cardiology consultations. Anesth Analg， 1998， 87：830-836.

3． Aronow WS and Ahn C， Incidence of heart failure in 2，737 older persons with and without diabetes mellitus. Chest， 1999， 115：867-868.

4． Practice guidelines for perioperative blood transfusion and adjuvant therapies：an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology， 2006， 105：198-208.

5． Eagle KA， Berger PB， Calkins H， et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery）. Anesth Analg， 2002， 94：1052-1064.

6． Reilly DF， McNeely MJ， Doerner D， et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med， 1999， 159：2185-2192.

7． Eagle KA， Rihal CS， Mickel MC， et al. Cardiac risk of noncardiac surgery：influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation， 1997， 96：1882-1887.

8． Castelli WP. Epidemiology of coronary heart disease：the Framingham study. Am J Med， 1984，76：4-12.

9． Brabant SM， Bertrand M， Eyraud D， et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg， 1999， 89：1388-1392.

10． Licker M， Schweizer A， Hohn L， et al. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors. Can J Anaesth，2000， 47：433-440.

11． Torsher LC， Shub C， Rettke SR， et al. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol， 1998， 81：448-452.

12． ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines（Committee on Management of Patients with Valvular Heart Disease）. J Am Coll Cardiol， 1998，32：1486-1588.

13． Blankensteijn JD， de Jong SE， Prinssen M， et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med， 2005， 352：2398-2405.

14． Lucas FL， Stukel TA， Mrris M， et al.， Race and surgical mortality in the United States. Ann Surg， 2006， 243：281-286.

15． Humar A， Kerr SR， Ramcharan T， et al. Peri-operative cardiac morbidity in kidney transplant recipients：incidence and risk factors. Clin Transplant， 2001， 15：154-158.

16． Schein OD， Katz J， Bass EB， et al. The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery. N Engl J Med， 2000， 342：168-175.

17． Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult：a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure）. J Am Coll Cardiol， 2005， 46：e1-82.

18． Torres MR， Short L， Baglin T， et al. Usefulness of clinical risk markers and ischemic threshold to stratify risk in patients undergoing major noncardiac surgery. Am J Cardiol， 2002， 90：238-242.

19． Tandogan I， Yetkin E， Yanik A， et al. Comparison of thallium-201 exercise SPECT and dobutamine stress echocardiography for diagnosis of coronary artery disease in patients with left bundle branch block. Int J Cardiovasc Imaging， 2001， 17：339-345.

20． Froehlich JB， Karacite D， Russman PL， et al. American College of Cardiology/American Heart Association preoperative assessment guidelines reduce resource utilization before aortic surgery. J Vasc Surg， 2002， 36：758-763.

21． Guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures（Subcommittee on Coronary Artery Bypass Graft Surgery）. J Am Coll Cardiol， 1991， 17：543-589.

22． Kaluza GL， Joseph J， Lee JR， et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol， 2000； 35：1288-1294.

23． Reddy PR and Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol，2005， 95：755-757.

24． Virmani R， Guagliumi G， Farb A， et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent：should we be cautious？ Circulation， 2004， 109：701-705.

25． Eisenstein EL， Anstrom KJ， Kong DF， et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA， 2007， 29：159-168.

26． Kastrati A， Mehilli J， Pache J， et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med， 2007， 356：1030-1039.

27． Burger W， Chemnitius JM， Kneissl GD， et al. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med， 2005， 257：399-414.

28． Juul AB， Wetterslev J， Gluud C， et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery：randomised placebo controlled， blinded multicentre trial. BMJ， 2006， 332：1482.

29． Feringa HH， Bax JJ， Boersma E， et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation，2006， 114：I344- I349.

30． Hindler K， Shaw AD， Samuels J， et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology， 2006， 105：1260-1272.

31． Wijeysundera DN， Naik JS and Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications：a meta-analysis. Am J Med， 2003， 114：742-752.

32． Levine MJ， Berman AD， Safian RD， et al. Palliation of valvular aortic stenosis by balloon valvuloplasty as preoperative preparation for noncardiac surgery. Am J Cardiol， 1988， 62：1309-1310.

33． Zipes DP， DiMarco JP， Gillette PC， et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures）， developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol， 1995， 26：555-573.

34． Kavarana MN， Azimuddin K， Agarwal A， et al. Hemodynamic monitoring in the elderly undergoing elective colon resection for cancer. Am Surg， 2003， 69：411-415.

35． Julier K， da Silva R， Garcia C， et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery：a doubleblinded， placebo-controlled， multicenter study. Anesthesiology， 2003， 98：1315-1327.

36． Bein B， Renner J， Caliebe D， et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg， 2005， 100：610-616.

37． Ouattara A， Lecomte O， Le MY， et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology，2005， 103：687-694.

38． Le Manach Y， Perel A， Coriat P， et al. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology， 2005， 102：885-891.